Skip to content
10-Q

Quarterly Report

COLUCID PHARMACEUTICALS, INC.

0001564590-15-010337

← back to feed
Filed
Nov 10, 2015 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2015 · Nov 10, 2015 15.15M sh
Cash And Equivalents Q3 2015 · Sep 30, 2015 $36.02M
Cash And Equivalents Q3 2015 · Sep 30, 2014 $581.85K
Cash And Equivalents Q3 2015 · Dec 31, 2013 $333K
Stockholders Equity Q3 2015 · Sep 30, 2015 $68.52M
Stockholders Equity Q3 2015 · Dec 31, 2014 −$1.79M
Current Liabilities Q3 2015 · Sep 30, 2015 $5.63M
Current Liabilities Q3 2015 · Dec 31, 2014 $581.55K
Total Liabilities Q3 2015 · Sep 30, 2015 $7.13M
Total Liabilities Q3 2015 · Dec 31, 2014 $2.08M
Current Assets Q3 2015 · Sep 30, 2015 $70.7M
Current Assets Q3 2015 · Dec 31, 2014 $227.07K
Total Assets Q3 2015 · Sep 30, 2015 $75.65M
Total Assets Q3 2015 · Dec 31, 2014 $293.25K
Net Income Q3 2015 · Dec 31, 2014 −$3M
Net Income Q3 2015 · Sep 30, 2014 −$714.93K
Net Income Q3 2015 · Sep 30, 2014 −$2.39M
Net Income Q3 2015 · Dec 31, 2013 −$2.2M
Sga Expense Q3 2015 · Sep 30, 2014 $293.22K
Sga Expense Q3 2015 · Sep 30, 2014 $925.51K
Rd Expense Q3 2015 · Sep 30, 2014 $382.11K
Rd Expense Q3 2015 · Sep 30, 2014 $818.7K
Operating Income Q3 2015 · Sep 30, 2014 −$675.33K
Operating Income Q3 2015 · Sep 30, 2014 −$1.74M